Description

This issue of Vital Signs, released on November 1, 2010, provides a strategic overview of key issues and trends relating to contract research outsourcing. Additionally, a company spotlight is provided for Accelovance, a vaccine-focused CRO that has established itself in delivering an innovative and proven approach to accelerated clinical development. Reimbursement and regulatory news from the FDA is also provided for the week of October 11, 2010.